This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Nestec S.a., Societe Des Produits Nestle S.a., Other. Active years: 2011-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dundas, CA (2011)
- Ottawa, CA (2012)
- Ontario, CA (2018 - 2024)
Company Filing History:
2 out of 2,371 
2 out of 1,288 
1 out of 834,601 Years Active: 2011-2024
Title: Innovative Contributions of Stephen Michael Collins in Probiotic Research
Introduction
Stephen Michael Collins, an accomplished inventor based in Ontario, CA, has made significant strides in the field of probiotic bacteria and its relation to gastrointestinal health. With a portfolio consisting of five patents, Collins has been dedicated to developing methods for treating and preventing functional gastrointestinal (GI) disorders, showcasing his expertise and commitment to innovation in this important area of research.
Latest Patents
Collins’ latest patents focus on the development and administration of probiotic bacteria for addressing functional GI disorders. His innovative methods encompass the use of specific strains, such as ATCC BAA-999, to provide therapeutic effects and alleviate symptoms associated with these conditions. This pioneering work not only contributes to the scientific understanding of probiotics but also offers potential solutions for individuals suffering from functional GI disorders.
Career Highlights
Throughout his career, Stephen Michael Collins has worked with notable organizations, including Nestlé and Nestec S.A., where he honed his skills as an innovator. His dedication to research and development in the food and health sectors has been a driving force behind his successful patent applications.
Collaborations
Collins has collaborated with esteemed colleagues in his field, including Elena Verdu De Bercik and Premysl Bercik. These collaborations have enhanced his innovative endeavors, allowing for a rich exchange of knowledge and ideas that have propelled his research forward.
Conclusion
Stephen Michael Collins stands as a noteworthy figure in the realm of innovations related to probiotic bacteria and functional GI disorders. His five patents not only reflect his ingenuity but also signify his commitment to improving gastrointestinal health through scientific advancements. As ongoing research in this field continues to evolve, his contributions will undoubtedly pave the way for future innovations and better treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile